OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sequence‑dependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action
ABDUL-MAJEED BAHMAN, Mohamed Salah I. Abaza, Sarah Khoushiash, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 41
ABDUL-MAJEED BAHMAN, Mohamed Salah I. Abaza, Sarah Khoushiash, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 41
Showing 26-50 of 41 citing articles:
Deoxyelephantopin, a germacrane‐type sesquiterpene lactone from Elephantopus scaber, induces mitochondrial apoptosis of hepatocarcinoma cells by targeting Hsp90α in vitro and in vivo
Jing‐Jie Chen, Qiulin Yan, Ming Bai, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 2, pp. 702-716
Closed Access | Times Cited: 11
Jing‐Jie Chen, Qiulin Yan, Ming Bai, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 2, pp. 702-716
Closed Access | Times Cited: 11
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
Song Gao, Xingyue Jiang, Liang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Song Gao, Xingyue Jiang, Liang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib
Zhonghao Jiang, Chaoliu Dai
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 257-266
Open Access | Times Cited: 5
Zhonghao Jiang, Chaoliu Dai
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 257-266
Open Access | Times Cited: 5
Nano lipidic carriers for codelivery of sorafenib and ganoderic acid for enhanced synergistic antitumor efficacy against hepatocellular carcinoma
Bin Wang, Lin Sun, Mingyun Wen, et al.
Saudi Pharmaceutical Journal (2021) Vol. 29, Iss. 8, pp. 843-856
Open Access | Times Cited: 10
Bin Wang, Lin Sun, Mingyun Wen, et al.
Saudi Pharmaceutical Journal (2021) Vol. 29, Iss. 8, pp. 843-856
Open Access | Times Cited: 10
Development and optimization of a self micro-emulsifying drug delivery system (SMEDDS) for co-administration of sorafenib and curcumin
Xingzhen Huang, Lizhen Feng, Xuefang Lu, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 1
Xingzhen Huang, Lizhen Feng, Xuefang Lu, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 1
Polymeric Nanocarriers for Effective Synergistic Action of Sorafenib Tosylate and Gold-sensitized Gamma Radiation Against HepG2 Cells
Firas Sukkar, Medhat W. Shafaa, M. S. El‐Nagdy, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 8309-8321
Open Access | Times Cited: 8
Firas Sukkar, Medhat W. Shafaa, M. S. El‐Nagdy, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 8309-8321
Open Access | Times Cited: 8
Diallyl Disulfide Induces Chemosensitization to Sorafenib, Autophagy, and Cell Cycle Arrest and Inhibits Invasion in Hepatocellular Carcinoma
Ana Rita Thomazela Machado, Katiuska Tuttis, Patrick Santos, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2582-2582
Open Access | Times Cited: 6
Ana Rita Thomazela Machado, Katiuska Tuttis, Patrick Santos, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2582-2582
Open Access | Times Cited: 6
Natural Compounds as Integrative Therapy for Liver Protection against Inflammatory and Carcinogenic Mechanisms: From Induction to Molecular Biology Advancement
Antara Banerjee, Sushmitha Sriramulu, Roberto Catanzaro, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 3, pp. 216-231
Closed Access | Times Cited: 4
Antara Banerjee, Sushmitha Sriramulu, Roberto Catanzaro, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 3, pp. 216-231
Closed Access | Times Cited: 4
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
Sonia Simón Serrano, Michele Tavecchio, Josef Mallik, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4553-4553
Open Access | Times Cited: 4
Sonia Simón Serrano, Michele Tavecchio, Josef Mallik, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4553-4553
Open Access | Times Cited: 4
Carnosic acid increases sorafenib-induced inhibition of ERK1/2 and STAT3 signaling which contributes to reduced cell proliferation and survival of hepatocellular carcinoma cells
Xuening Wang, Priya Gupta, Yasmeen Jramne, et al.
Oncotarget (2020) Vol. 11, Iss. 33, pp. 3129-3143
Open Access | Times Cited: 5
Xuening Wang, Priya Gupta, Yasmeen Jramne, et al.
Oncotarget (2020) Vol. 11, Iss. 33, pp. 3129-3143
Open Access | Times Cited: 5
Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells
ABDUL-MAJEED BAHMAN, Mohamed‐Salah I. Abaza, Sarah Khoushaish, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
ABDUL-MAJEED BAHMAN, Mohamed‐Salah I. Abaza, Sarah Khoushaish, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Enhanced Cytotoxicity of Sorafenib in Hepatocellular Carcinoma through Synergistic Combination with Naringenin: A Molecular and Cellular Perspective
Doha E Gouda, Ahmed I. Abulsoud, Noha Abdel-Rahman Eldesoky
Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences (2024)
Open Access
Doha E Gouda, Ahmed I. Abulsoud, Noha Abdel-Rahman Eldesoky
Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences (2024)
Open Access
Protective effect of deinoxanthin in sorafenib-induced nephrotoxicity in rats with the hepatocellular carcinoma model
Nilgun Karasu, Mehmet Kuzucu, Özge Cengiz Mat, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Nilgun Karasu, Mehmet Kuzucu, Özge Cengiz Mat, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Isotretinoin and Thalidomide Down-Regulate c-MYC Gene Expression and Modify Proteins Associated with Cancer in Hepatic Cells
Patricia Nefertari Ramírez-Flores, Paulina J. Barraza-Reyna, Alain Aguirre-Vázquez, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5742-5742
Open Access | Times Cited: 3
Patricia Nefertari Ramírez-Flores, Paulina J. Barraza-Reyna, Alain Aguirre-Vázquez, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5742-5742
Open Access | Times Cited: 3
Multiple targets modulation of Bcl-2/CD1, caspase-3 and refinement of AKT/ERK signalling by sorafenib in hepatocellular carcinoma in rats; comprehensive outlook
Mohamed A. Hamzawy, Laila A. Rahsed, Sayed M. Mizar
Egyptian Pharmaceutical Journal (2023) Vol. 22, Iss. 3, pp. 508-515
Closed Access
Mohamed A. Hamzawy, Laila A. Rahsed, Sayed M. Mizar
Egyptian Pharmaceutical Journal (2023) Vol. 22, Iss. 3, pp. 508-515
Closed Access
EFFECT OF SORAFENIB ON HUMAN COLON CANCER CELLS
Marwa Al Hassan, Farah Reda, Ali Baltaji, et al.
BAU Journal - Health and Wellbeing (2021) Vol. 3, Iss. 2
Open Access
Marwa Al Hassan, Farah Reda, Ali Baltaji, et al.
BAU Journal - Health and Wellbeing (2021) Vol. 3, Iss. 2
Open Access
Induction of Anti-Proliferative and Apoptotic Effects of Sorafenib Using miR-27a Inhibitor in Hepatocellular Carcinoma Cell Lines
Abdel Hady A. Abdel Wahab, Eman Ayad, Mohga S. Abdulla, et al.
Asian Pacific Journal of Cancer Prevention (2021) Vol. 22, Iss. 9, pp. 2951-2958
Open Access
Abdel Hady A. Abdel Wahab, Eman Ayad, Mohga S. Abdulla, et al.
Asian Pacific Journal of Cancer Prevention (2021) Vol. 22, Iss. 9, pp. 2951-2958
Open Access
